Danish Company Coloplast Sets Over $100 Million Aside for Transvaginal Mesh Litigation
Pharmaceutical and medical device manufacturer Coloplast, based in Denmark, announced on Friday, May 2nd, that the company had reserved one billion Danish krones – which is over $100 million – to help pay for transvaginal mesh litigation in the United States.
Since 2011, the Danish company has been a defendant in a transvaginal mesh multidistrict litigation (MDL) alleging serious personal injury due to the company’s transvaginal mesh devices.
The company said that its total expected costs in the US due to transvaginal mesh litigation are 1.5bn DKK.
“With the information currently available to us we believe that our insurance coverage is insufficient and we have made a provision”, states Coloplast CFO
“Coloplast stands by its surgical mesh devices and is prepared to enter litigation. However, if we believe seeking settlements is the right business decision, we will pursue them. Although we have proposed settlements, Coloplast does not admit any liability or that its devices are unsafe,” the company stated in a press release.
In early March of this year, the company paid $16 million to settle some of the transvaginal mesh personal injury cases in the MDL. The amount covered about 400 lawsuits, with $40,000 for each plaintiff.
Coloplast is one of six transvaginal mesh manufacturers facing a multidistrict litigation that houses thousands of personal injury lawsuits which allege that transvaginal mesh devices have done serious damage to the plaintiff. Johnson & Johnson’s Ethicon Unit is the only company so far that has not indicated that they will pursue settlement talks in their transvaginal mesh MDL. “Ethicon is now focusing on trying to efficiently manage thousands of unverified and possibly unfounded complaints,” Sheri Woodruff, a spokeswoman for the Ethicon unit of New Brunswick, New Jersey-based J&J, said in an e-mail. The company will “request dismissal of meritless claims, including claims with no compensable injury, claims barred by the statute of limitations, misfiled claims, and improperly filed claims.”
In a monumental settlement agreement on Wednesday, April 30th, Endo Pharmaceuticals and subsidiary American Medical Systems agreed to settle their transvaginal mesh injury claims for $830 million. As of February 20th, the company faced 22,000 personal injury lawsuits alleging injuries due to transvaginal mesh implants. The company agreed last year to pay $54.5 million to settle some of the transvaginal mesh personal injury claims in the MDL. The company stated previously that it had set aside $520 million to cover settlements with the plaintiffs.
The Strom Law Firm Fights for Women in Transvaginal Mesh Personal Injury Case
Transvaginal mesh kits were initially produced to help with pelvic organ prolapse and stress urinary incontinence. Several varieties of mesh kits exist, but transvaginal mesh specifically was supposed to produce less scarring and pain, because the procedure was less invasive. However, vaginal mesh slings can cause a host of problems, including organ perforation, infection, internal scarring, continued organ prolapse, and bleeding. If you or a loved one has pelvic organ prolapse or stress urinary incontinence, have had a transvaginal mesh device implanted, and have since experienced detrimental complications, you may be entitled to compensation. The experienced lawyers at Strom Law, LLC can help. We offer free consultations, so please contact us today, and we can help get you on the road to recovery. 803.252.4800